TABLE 3.

Quality of studies on measurement properties

PROM	Article	Structural validity	Internal consistency	Cross-cultural validity	Reliability	Measurement error	Criterion validity	Construct validity		Responsiveness
								Convergent validity	Known groups validity	Comparison with gold standard	Comparison with other instruments	Comparison between subgroups	Comparison before and after intervention
BCLE-SEI	Shi et al., 201621	A	V		I		D	D	D
FLQA-I	Augustin et al., 200522		V		I			A	I				I
FLQA-LS	Augustin et al., 201837	I	V					D
LISS	Weiss and Daniel, 201528		V		I		V	D	D				D
	Degirmenci et al., 201939	D	V		I			D
	Haghighat et al., 201840	D	V		I			A	I
LLIS 2.0	Weiss and Daniel, 201823		V		I	I	I	A
	Orhan et al., 202041	D	D		I		D		I
	Abu Sharour, 202042	I	V					D
LSIDS-A	Ridner and Dietrich, 201529		V		I			A
LSIDS-H&N	Deng et al., 201230
LSIDS-L	Ridner et al., 201835		V					D	D
Lymph-ICF	Devoogdt et al., 201131		V		I	I		A	A
	Kostanoglu et al., 201643		V		I	I	I	A
	Grarup et al., 201944		V		I	I
Lymph-ICF-UL	De Vrieze et al., 201927		V		I	I		A
Lymph-ICF-LL	Devoogdt et al., 201432		V		I	I		A
	Kostanoglu et al., 201745		V		I			A
	Wang et al., 201846	I	V		I		D
LYMQOL	Keeley et al., 201033		V		I	I	D	I					D
LYMQOL-arm	Bakar et al., 201747	I	V		D	I	I	D
	Borman et al., 201848	A	V		I			V
	Karayurt et al., 201949	A	V						I
LYMQOL-leg	van de Pas et al., 201650	I	V		I	I		A
	Bakar and Tuğral, 201951	I	V		D		V
	Borman et al., 202052	A	V		I			A	D
LyQLI	Klernäs et al., 201538	D	V		I			A
	Klernäs et al., 201836										A		V
PBI-L	Blome et al., 201424	A	V					A					I
	Duygu et al., 202053		V		I			D
(S)LQOLI	Klernäs et al., 201025				D			A
ULL-27	Launois and Alliot 200034	I	V		I			D			I	I
	Launois et al., 200218	V	V		I		V	A	D			D
	Viehoff et al., 200854		V				D	D	D
ULLQoL	Williams et al., 201826	A	V		I			A				D

Empty cells indicate that no information was available on this item

PROM patient-reported outcome measure, V very good, A adequate, D doubtful, I inadequate